Corrigendum to “European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults” [Clin Microbiol and Infect 30(1) (2024 Jan) 66–89 Doi: 10.1016/j.cmi.2023.08.016] (Clinical Microbiology and Infection (2024) 30(1) (66–89), (S1198743X23003993), (10.1016/j.cmi.2023.08.016))
dc.contributor.author | Bodilsen J. | |
dc.contributor.author | D'Alessandris Q.G. | |
dc.contributor.author | Humphreys H. | |
dc.contributor.author | Iro M.A. | |
dc.contributor.author | Klein M. | |
dc.contributor.author | Last K. | |
dc.contributor.author | Montesinos I.L. | |
dc.date.accessioned | 2024-08-31T07:42:26Z | |
dc.date.available | 2024-08-31T07:42:26Z | |
dc.date.issued | 2024 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The authors regret an inconsistency in the reported quality of evidence for Key Question 4 concerning whether neurosurgical aspiration or excision should be used in patients with brain abscess. The reported quality of evidence was described as “low” in the abstract and Table 1 and should instead be “moderate” as stated in the main text. The authors would like to apologise for any inconvenience caused. © 2024 The Author(s) | en_US |
dc.identifier.doi | 10.1016/j.cmi.2024.01.026 | |
dc.identifier.issn | 1198-743X | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 38309325 | en_US |
dc.identifier.scopus | 2-s2.0-85187290455 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 698 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.cmi.2024.01.026 | |
dc.identifier.uri | https://hdl.handle.net/11454/103876 | |
dc.identifier.volume | 30 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier B.V. | en_US |
dc.relation.ispartof | Clinical Microbiology and Infection | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240831_U | en_US |
dc.subject | adult | en_US |
dc.subject | brain abscess | en_US |
dc.subject | child | en_US |
dc.subject | communicable disease | en_US |
dc.subject | controlled study | en_US |
dc.subject | diagnosis | en_US |
dc.subject | drug therapy | en_US |
dc.subject | erratum | en_US |
dc.subject | human | en_US |
dc.subject | infection | en_US |
dc.subject | microbiology | en_US |
dc.subject | nonhuman | en_US |
dc.subject | oral drug administration | en_US |
dc.subject | practice guideline | en_US |
dc.subject | surgery | en_US |
dc.subject | drug comparison | en_US |
dc.subject | European | en_US |
dc.title | Corrigendum to “European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults” [Clin Microbiol and Infect 30(1) (2024 Jan) 66–89 Doi: 10.1016/j.cmi.2023.08.016] (Clinical Microbiology and Infection (2024) 30(1) (66–89), (S1198743X23003993), (10.1016/j.cmi.2023.08.016)) | en_US |
dc.type | Erratum | en_US |